PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Malaria drug target raises hopes for new treatments

2013-12-27
(Press-News.org) Contact information: Gail Wilson
gail.wilson@imperial.ac.uk
44-207-594-6702
Imperial College London
Malaria drug target raises hopes for new treatments Scientists have taken an important step towards new malaria treatments by identifying a way to stop malaria parasites from multiplying. In a study published in Nature Chemistry, they show that blocking the activity of an enzyme called NMT in the most common malaria parasite prevents mice from showing symptoms and extends their lifespan. The team are working to design molecules that target NMT more potently, and hope to start clinical trials of potential treatments within four years. A recent study estimated that 1.2 million people died from malaria in 2010. Although a variety of antimalarial drugs are available, some strains of the parasite are resistant to treatment. These strains are becoming more common, with treatment failures reported across multiple frontline drugs. If acute illness is cured, the parasite can remain dormant in the blood and return to cause illness later. Malaria vaccines have been researched intensively, but none have been introduced into clinical practice. The new study shows that NMT is involved in a wide range of essential processes in the parasite cell, including the production of proteins that enable malaria to be transmitted between humans and mosquitoes, and proteins that enable malaria to cause long-term infection. The researchers have tested a handful of molecules that block the activity of NMT in the parasite living inside human red blood cells, and in mice, but further refinement will be needed before a treatment is ready to be tested in humans. Dr Ed Tate, from the Department of Chemistry at Imperial College London, who led the project, said: "The drug situation for malaria is becoming very serious. Resistance is emerging fast and it's going to be a huge problem in the future. "Finding an enzyme that can be targeted effectively in malaria can be a big challenge. Here, we've shown not only why NMT is essential for a wide range of important processes in the parasite, but also that we can design molecules that stop it from working during infection. It has so many functions that we think blocking it could be effective at preventing long-term disease and transmission, in addition to treating acute malaria. We expect it to work not just on Plasmodium falciparum, the most common malaria parasite, but the other species as well. "We need to do some more work in the lab to find the best candidate molecule to take into clinical trials, but hopefully we'll be ready to do that within a few years." ### The discovery is the culmination of a five-year project by a consortium of researchers from Imperial College London, the MRC National Institute for Medical Research, the University of Nottingham, the University of York, and Pfizer, funded by the Medical Research Council, the Engineering and Physical Sciences Research Council, and the Biotechnology and Biological Sciences Research Council. For more information please contact: Gail Wilson
Research Media Officer
Imperial College London
Email: gail.wilson@imperial.ac.uk
Tel: +44(0)20 7594 6702
Out of hours duty press officer: +44(0)7803 886 248 Notes to editors 1. M.H. Wright et al. 'Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach.' Nature Chemistry, 2013. After the embargo the paper will be available at: http://dx.doi.org/10.1038/nchem.1830 2. About Imperial College London Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture. Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges. In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible. Website: http://www.imperial.ac.uk 3. About the University of York The University of York was founded in 1963 with 200 students. It now has 15,000 students and more than 30 academic departments and research centres. It is a member of the Russell Group and features regularly in the ranks of the UK's foremost universities. In 2012 two international league tables of the most successful young universities ranked York as No 1 in the UK and No 6 in the world. It was named Times Higher Education University of the Year in 2010 for its drive to combine academic excellence with social inclusion, and its record in scientific discovery and investment in the arts and humanities. The University has won five Queen's Anniversary Prizes for the quality of its research. The University of York places equal emphasis on research and teaching. Students in every academic department - both undergraduate and postgraduate - are taught and advised by leaders in their field. The University has a collegiate system in which most staff and all students are members of one of eight colleges, with a ninth under construction. http://www.york.ac.uk END


ELSE PRESS RELEASES FROM THIS DATE:

Innovative screening strategy swiftly uncovers new drug candidates, new biology

2013-12-27
Innovative screening strategy swiftly uncovers new drug candidates, new biology Scripps Research Institute scientists use method to identify compound with promise for obesity-linked diabetes LA JOLLA, CA—December 22, 2013—Scientists at The Scripps Research Institute ...

'Be different or die' does not drive evolution

2013-12-27
'Be different or die' does not drive evolution A new study has found that species living together are not forced to evolve differently to avoid competing with each other, challenging a theory that has held since Darwin's Origin of Species. By ...

Greenland ice stores liquid water year-round

2013-12-27
Greenland ice stores liquid water year-round Potential for storing meltwater important for calculating sea-level rise Dec. 22, 2013 – Researchers at the University of Utah have discovered a new aquifer in the Greenland Ice Sheet that holds liquid water all ...

Researchers create largest evolutionary 'timetree' of land plants to investigate traits that permit survival in cold climates

2013-12-27
Researchers create largest evolutionary 'timetree' of land plants to investigate traits that permit survival in cold climates A team of researchers studying plants has assembled the largest dated evolutionary tree, using it to show the order in which flowering plants ...

Solar activity not a key cause of climate change, study shows

2013-12-27
Solar activity not a key cause of climate change, study shows Climate change has not been strongly influenced by variations in heat from the sun, a new scientific study shows Climate change has not been strongly influenced by variations in heat from the ...

York scientists' significant step forward in biofuels quest

2013-12-27
York scientists' significant step forward in biofuels quest Scientists at the University of York have made a significant step in the search to develop effective second generation biofuels. Researchers from the Department of Chemistry at York have discovered ...

Scientists anticipated size and location of 2012 Costa Rica earthquake

2013-12-27
Scientists anticipated size and location of 2012 Costa Rica earthquake Scientists using GPS to study changes in the Earth's shape accurately forecasted the size and location of the magnitude 7.6 Nicoya earthquake that occurred in 2012 in Costa Rica. The Nicoya ...

The analogue of a tsunami for telecommunication

2013-12-27
The analogue of a tsunami for telecommunication Development of electronics and communication requires a hardware base capable for increasingly larger precision, ergonomics and throughput. For communication and GPS-navigation satellites, it is of great importance ...

Study: Some plants may not adapt quickly to future climate change

2013-12-27
Study: Some plants may not adapt quickly to future climate change GAINESVILLE, Fla. --- Using the largest dated evolutionary tree of flowering plants ever assembled, a new study suggests how plants developed traits to withstand low temperatures, with implications ...

Solitons in a crystal

2013-12-27
Solitons in a crystal Soliton water waves can travel several kilometers without any significant change in their shape or amplitude, as opposed to normal waves, which widen as they travel, and eventually disappear. Discovered over 150 years ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Malaria drug target raises hopes for new treatments